Earlier this month, the Trump administration directed the National Institutes of Health (NIH) to impose limits on specific ...

Information related to the IRB submission process. The UB IRB has updated the HRP-503 Template Protocol (IRB Version: JAN2016). All new studies submitted on or after April 1, 2016 must be submitted ...

The review and oversight of research involving human subjects or identifiable data derived from human subjects is the charge of a federally mandated committee called an Institutional Review Board, or ...

The IRB will also accept NIH Human Subject Research training certificates. The IRB will also accept training considered by the IRB to be equivalent to CITI and NIH training. The IRB reviews ...

Jul 30, 2017 Aug 03, 2017 Interest First Distribution for units of IRB InvIT Fund of Rs.1.55 per Unit - The distribution will be paid as Rs.1.05/- per Unit as Interest and Re.0.50/- per Unit as ...

National Institutes of Health (NIH) Acting Director Matthew Memoli sought to clarify the extent of the Trump administration's freeze on communications and other functions within the Health and ...

Just about everyone online was either employed by, or receiving grants from, the National Institutes of Health (NIH), the largest single funder of biomedical and behavioral research in the world.

Investigational Review Board (IRB) approval has been granted for the open-label study to evaluate tafenoquine for treatment of patients with a presumptive diagnosis of chronic babesiosis in ...

60 Degrees Pharmaceuticals (SXTP) announced the approval of an Investigational Review Board, IRB, sanctioned Phase II clinical study. The study will evaluate the efficacy and safety of the ARAKODA ...

This is happening at the same time as a broader ban on all external communication by the NIH and other agencies that fall under Health and Human Services through Feb. 1. The NIH is the biggest ...

"Procurement, contracting, traveling and hiring at NIH are continuing for anything directly related to human safety, human or animal healthcare, security, biosafety, biosecurity and IT security ...

A new memo by NIH Acting Director Matthew Memoli, obtained by Forbes, clarifies what can and can’t be done with regard to clinical trials, purchasing, research publications and public appearances.